Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...

Panelists discuss how their lived experiences and insights as patients should inform research priorities, treatment development, and care delivery improvements while sharing hopes for a future cure ...

Panelists discuss how they maintain treatment adherence through digital health apps, calendar reminders, and symptom journals while working closely with their care teams to address uncertainties and ...

Panelists discuss how they navigated initial treatment confusion by seeking clarification from healthcare providers, consulting patient resources, and connecting with support groups to better ...

Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...

C, BSN, RN, discussed taking advantage of available resources to provide comprehensive care for patients with breast cancer.

Dr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for ...

Patient-reported outcomes were consistent between patients with RCC using tivozanib/nivolumab and tivozanib monotherapy according to study findings. The combination of tivozanib (Fotivda) and ...

Aspirin Linked to Lower CRC Recurrence in Patients With PI3K Mutations ...

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.